dc.contributor.author | Albayrak, D | |
dc.contributor.author | Islek, I | |
dc.contributor.author | Kalayci, Ag | |
dc.contributor.author | Gurses, N | |
dc.date.accessioned | 2020-06-21T11:31:52Z | |
dc.date.available | 2020-06-21T11:31:52Z | |
dc.date.issued | 1994 | |
dc.identifier.issn | 0022-3476 | |
dc.identifier.issn | 1097-6833 | |
dc.identifier.uri | https://doi.org/10.1016/S0022-3476(05)82024-4 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/9915 | |
dc.description | WOS: A1994PW57200027 | en_US |
dc.description | PubMed: 7996346 | en_US |
dc.description.abstract | We compared very high doses of methylprednisolone with intravenously administered immune globulin for treatment of acute idiopathic thrombocytopenic purpura. Fifty-seven children were randomly assigned to receive the immune globulin preparation, 0.5 gm/kg per day for 5 consecutive days (n = 19), orally administered methylprednisolone, 30 mg/kg per day for 7 days (n = 19), or orally administered methylprednisolone, 50 mg/kg per day for 7 days (n = 19), There were no differences in the response of the platelet counts among the groups, We conclude that these two therapies were equally effective; choice between them may be made according to cost and therapy-related risks. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Mosby-Elsevier | en_US |
dc.relation.isversionof | 10.1016/S0022-3476(05)82024-4 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Acute Immune Thrombocytopenic Purpura - A Comparative-Study of Very High Oral Doses of Methylprednisolone and Intravenously Administered Immune Globulin | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 125 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.startpage | 1004 | en_US |
dc.identifier.endpage | 1007 | en_US |
dc.relation.journal | Journal of Pediatrics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |